Sugi Predict

Sugi Predict / Compounds / SCHEMBL391406

SCHEMBL391406

SCHEMBL391406

CC(C)(C)OC(=O)NC(CS(N)(=O)=O)c1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 1/20 0.43
▸ PPARA Q07869 1/20 0.43
▸ CA2 P00918 5/20 0.43
▸ CA1 P00915 4/20 0.43
▸ CA9 Q16790 4/20 0.43
▸ CA4 P22748 1/20 0.43
▸ CA7 P43166 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ TRPA1 O75762 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ P2RY2 P41231 1/20 0.40
▸ CACNA1B Q00975 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ S1PR3 Q99500 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ AKT1 P31749 1/20 0.39
▸ CA12 O43570 3/20 0.39
▸ CTSS P25774 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL393273 0.90 PPARG (0.43) PPARGPPARACA2CA1CA9
SCHEMBL392960 0.89 CA2 (0.43) PPARGPPARACA2CA1CA9
SCHEMBL392217 0.85 PPARG (0.46) PPARGPPARAALDH1A1MAPTTRPA1
SCHEMBL14847725 0.83 GAA (0.48) PPARGPPARAALDH1A1MAPTTRPA1
SCHEMBL393133 0.83 GAA (0.48) PPARGPPARAALDH1A1MAPTTRPA1
SCHEMBL391415 0.83 PPARG (0.44) PPARGPPARAALDH1A1MAPTTRPA1
SCHEMBL17619244 0.83 P2RY2 (0.45) PPARGPPARAALDH1A1MAPTTRPA1
SCHEMBL390232 0.83 P2RY2 (0.45) PPARGPPARAALDH1A1MAPTTRPA1
SCHEMBL20544831 0.82 PPARG (0.46) PPARGPPARAALDH1A1MAPTTRPA1
SCHEMBL391128 0.82 PPARG (0.46) PPARGPPARAALDH1A1MAPTTRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12252495-B2 Protein kinase B inhibitors ASTRAZENECA AB (SE) 2025-03-18 — — US disclosed
US-20240109902-A1 PROTEIN KINASE B INHIBITORS ASTRAZENECA AB (SE) 2024-04-04 — — US disclosed
US-11760760-B2 Protein kinase B inhibitors ASTRAZENECA AB (SE) 2023-09-19 — — US disclosed
US-11760760-B2 Protein kinase B inhibitors ASTRAZENECA AB (SE) 2023-09-19 — — US disclosed
US-11760760-B2 Protein kinase B inhibitors ASTRAZENECA AB (SE) 2023-09-19 — — US disclosed
US-20220220116-A1 PROTEIN KINASE B INHIBITORS ASTRAZENECA AB (SE) 2022-07-14 — — US disclosed
US-20220220116-A1 PROTEIN KINASE B INHIBITORS ASTRAZENECA AB (SE) 2022-07-14 — — US disclosed
US-11236095-B2 Protein kinase B inhibitors ASTRAZENECA AB (SE) 2022-02-01 — — US disclosed
US-11236095-B2 Protein kinase B inhibitors ASTRAZENECA AB (SE) 2022-02-01 — — US disclosed
US-20200239483-A1 PROTEIN KINASE B INHIBITORS ASTRAZENECA AB (SE) 2020-07-30 — — US disclosed
US-20150182531-A1 Novel Protein Kinase B Inhibitors - 060 ASTRAZENECA AB (SE) 2015-07-02 — — US disclosed
US-20120190679-A1 Novel Protein Kinase B Inhibitors - 060 ASTRAZENECA AB (SE) 2012-07-26 — — US disclosed
US-20120190679-A1 Novel Protein Kinase B Inhibitors - 060 ASTRAZENECA AB (SE) 2012-07-26 — — US disclosed
US-20120190679-A1 Novel Protein Kinase B Inhibitors - 060 ASTRAZENECA AB (SE) 2012-07-26 — — US disclosed
US-8101623-B2 Substituted pyrrolo[2,3-d]pyrimidine as a protein kinase B inhibitor ASTRAZENECA AB (SE) 2012-01-24 — — US disclosed
US-8101623-B2 Substituted pyrrolo[2,3-d]pyrimidine as a protein kinase B inhibitor ASTRAZENECA AB (SE) 2012-01-24 — — US disclosed
US-8101623-B2 Substituted pyrrolo[2,3-d]pyrimidine as a protein kinase B inhibitor ASTRAZENECA AB (SE) 2012-01-24 — — US disclosed
US-20090163524-A1 Novel Protein Kinase B Inhibitors - 060 ASTRAZENECA AB (SE) 2009-06-25 — — US disclosed
US-20090163524-A1 Novel Protein Kinase B Inhibitors - 060 ASTRAZENECA AB (SE) 2009-06-25 — — US disclosed
US-20090163524-A1 Novel Protein Kinase B Inhibitors - 060 ASTRAZENECA AB (SE) 2009-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12252495-B2 Protein kinase B inhibitors PRKAR2B, PRKCB, AKT1 PPARG 3405/4885PPARA 4173/4885CA2 1925/4885
US-20220220116-A1 PROTEIN KINASE B INHIBITORS PRKAR2B, PRKCB, AKT1 PPARG 3405/4885PPARA 4173/4885CA2 1925/4885
US-20240109902-A1 PROTEIN KINASE B INHIBITORS PRKAR2B, PRKCB, AKT1 PPARG 3405/4885PPARA 4173/4885CA2 1925/4885
US-20090163524-A1 Novel Protein Kinase B Inhibitors - 060 PRKAR2B, PRKCB, MAP3K20 PPARG 3172/4885PPARA 3942/4885CA2 2920/4885
US-20200239483-A1 PROTEIN KINASE B INHIBITORS PRKAR2B, PRKCB, AKT1 PPARG 3405/4885PPARA 4173/4885CA2 1925/4885
US-20120190679-A1 Novel Protein Kinase B Inhibitors - 060 PRKAR2B, PRKCB, MAP3K20 PPARG 3172/4885PPARA 3942/4885CA2 2920/4885
US-11236095-B2 Protein kinase B inhibitors PRKAR2B, PRKCB, AKT1 PPARG 3405/4885PPARA 4173/4885CA2 1925/4885
US-20150182531-A1 Novel Protein Kinase B Inhibitors - 060 PRKAR2B, PRKCB, MAP3K20 PPARG 3172/4885PPARA 3942/4885CA2 2920/4885
US-11760760-B2 Protein kinase B inhibitors PRKAR2B, PRKCB, AKT1 PPARG 3405/4885PPARA 4173/4885CA2 1925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.